自产原料药及中间体

Search documents
奥锐特:天台铂融减持约218万股,本次减持计划已实施完毕
Mei Ri Jing Ji Xin Wen· 2025-09-26 09:53
每经AI快讯,奥锐特(SH 605116,收盘价:22.33元)9月26日晚间发布公告称,截至本公告披露日, 天台铂融以集中竞价交易方式减持2,176,600股,占公司总股本的0.54%,本次减持计划已实施完毕。天 台铂融目前仍持有公司股份7,730,600股,占公司总股本的1.90%。 每经头条(nbdtoutiao)——5年增长33倍,这类新险种卖爆了,身边很多人都需要,30多家险企蜂拥而 入⋯⋯ (记者 曾健辉) 2025年1至6月份,奥锐特的营业收入构成为:自产原料药及中间体占比85.12%,制剂占比11.64%,贸 易占比2.74%,其他业务占比0.5%。 截至发稿,奥锐特市值为91亿元。 ...
奥锐特:累计回购141.42万股
Mei Ri Jing Ji Xin Wen· 2025-08-04 08:00
Group 1 - The company Aorite (SH 605116, closing price: 23.69 CNY) announced on August 4 that as of July 31, 2025, it has repurchased a total of 1.4142 million shares through the Shanghai Stock Exchange trading system, accounting for 0.35% of the current total share capital, with a total expenditure of approximately 28.22 million CNY [2] - The highest repurchase price was 21.3 CNY per share, while the lowest was 18.83 CNY per share [2] Group 2 - For the year 2024, the revenue composition of Aorite is as follows: self-produced raw materials and intermediates accounted for 77.29%, formulations accounted for 14.91%, trade accounted for 7.55%, and other businesses accounted for 0.25% [2]